Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multi-omics analysis defines highly refractory RAS burdened immature subgroup of infant acute lymphoblastic leukemia.
Isobe T, Takagi M, Sato-Otsubo A, Nishimura A, Nagae G, Yamagishi C, Tamura M, Tanaka Y, Asada S, Takeda R, Tsuchiya A, Wang X, Yoshida K, Nannya Y, Ueno H, Akazawa R, Kato I, Mikami T, Watanabe K, Sekiguchi M, Seki M, Kimura S, Hiwatari M, Kato M, Fukuda S, Tatsuno K, Tsutsumi S, Kanai A, Inaba T, Shiozawa Y, Shiraishi Y, Chiba K, Tanaka H, Kotecha RS, Cruickshank MN, Ishikawa F, Morio T, Eguchi M, Deguchi T, Kiyokawa N, Arakawa Y, Koh K, Aoki Y, Ishihara T, Tomizawa D, Miyamura T, Ishii E, Mizutani S, Wilson NK, Göttgens B, Miyano S, Kitamura T, Goyama S, Yokoyama A, Aburatani H, Ogawa S, Takita J. Isobe T, et al. Among authors: akazawa r. Nat Commun. 2022 Aug 30;13(1):4501. doi: 10.1038/s41467-022-32266-4. Nat Commun. 2022. PMID: 36042201 Free PMC article.
Inotuzumab ozogamicin following allogeneic hematopoietic stem cell transplantation successfully rescued relapse of CD19-negative acute lymphoblastic leukemia after CAR-T cell therapy.
Kamitori T, Umeda K, Akazawa R, Iwai A, Obu S, Isobe K, Saida S, Kato I, Hiramatsu H, Taga T, Adachi S, Takita J. Kamitori T, et al. Among authors: akazawa r. Pediatr Blood Cancer. 2021 May;68(5):e28980. doi: 10.1002/pbc.28980. Epub 2021 Feb 22. Pediatr Blood Cancer. 2021. PMID: 33619887 Free article. No abstract available.
Immature teratoma of the ovary associated with Cowden syndrome.
Kouzuki K, Umeda K, Kawasaki H, Isobe K, Akazawa R, Tasaka K, Tanaka K, Kubota H, Saida S, Kato I, Hiramatsu H, Sonoda M, Okamoto T, Ogawa E, Kishida K, Takita J. Kouzuki K, et al. Among authors: akazawa r. Pediatr Blood Cancer. 2022 Jul;69(7):e29555. doi: 10.1002/pbc.29555. Epub 2021 Dec 31. Pediatr Blood Cancer. 2022. PMID: 34971079 No abstract available.
Chimeric antigen receptor T-cell therapy for a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia and leukoencephalopathy who relapsed after bone marrow transplantation.
Kawabata N, Hiramatsu H, Mikami T, Akazawa R, Tanaka K, Kouzuki K, Kubota H, Saida S, Kato I, Umeda K, Hirate T, Kanda K, Adachi S, Takita J. Kawabata N, et al. Among authors: akazawa r. Pediatr Blood Cancer. 2022 Nov;69(11):e29734. doi: 10.1002/pbc.29734. Epub 2022 Apr 22. Pediatr Blood Cancer. 2022. PMID: 35451545 Free article. No abstract available.
Use of Cabozantinib to Treat MET -amplified Pediatric Colorectal Cancer.
Fukui S, Umeda K, Kubota H, Iwai A, Akazawa R, Isobe K, Tanaka K, Kouzuki K, Kawabata N, Saida S, Kato I, Hiramatsu H, Itatani Y, Funakoshi T, Adachi S, Takita J. Fukui S, et al. Among authors: akazawa r. J Pediatr Hematol Oncol. 2023 Apr 1;45(3):e423-e426. doi: 10.1097/MPH.0000000000002482. Epub 2022 May 3. J Pediatr Hematol Oncol. 2023. PMID: 35536994
Clinical Outcomes of Patients With Osteosarcoma Experiencing Relapse or Progression: A Single-institute Experience.
Umeda K, Sakamoto A, Noguchi T, Uchihara Y, Kobushi H, Akazawa R, Ogata H, Saida S, Kato I, Hiramatsu H, Uto M, Mizowaki T, Haga H, Date H, Okamoto T, Watanabe K, Adachi S, Toguchida J, Matsuda S, Takita J. Umeda K, et al. Among authors: akazawa r. J Pediatr Hematol Oncol. 2023 Apr 1;45(3):e356-e362. doi: 10.1097/MPH.0000000000002521. Epub 2022 Aug 10. J Pediatr Hematol Oncol. 2023. PMID: 35973000
Second relapse of FLT3-ITD-positive acute myeloid leukemia after discontinuation of 3-year post-transplant maintenance therapy with gilteritinib.
Tasaka K, Kato I, Takeshita S, Yoshioka Y, Usami A, Uchihara Y, Akazawa R, Kamitori T, Saida S, Umeda K, Hiramatsu H, Adachi S, Takita J. Tasaka K, et al. Among authors: akazawa r. Pediatr Blood Cancer. 2023 May;70(5):e30185. doi: 10.1002/pbc.30185. Epub 2022 Dec 29. Pediatr Blood Cancer. 2023. PMID: 36579805 No abstract available.
32 results